Julian Lewis MP: written questions
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Read what this MP said, asked and contributed in Parliament.
18 published records · newest first.
Written questions
Independent Review of Maternity Services at Nottingham University Hospitals NHS TrustDepartment of Health and Social CareTabled 30 Jun 2026AnsweredUIN 14304More
Question: To ask the Secretary of State for Health and Social Care, if he will publish the (a) names and (b) roles of all senior clinicians who declined to take part in the Ockenden Review of Nottingham Maternity and Neonatal Services.
Answer: The Nottingham University Hospitals NHS Trust Maternity and Neonatal Review led by Donna Ockenden is an independent review. Therefore, the Department does not hold information about those individuals who declined to participate.The Public Office (Accounta...
Answered 8 Jul 2026
Original Parliament recordSodium Valproate and Surgical Mesh Implants: CompensationDepartment of Health and Social CareTabled 29 Jun 2026AnsweredUIN 13757More
Question: To ask the Secretary of State for Health and Social Care, if he will take steps to supply the Patient Safety Commissioner, by 16 July 2026, with the information she has formally requested on (a) Government discussions, (b) actions taken across Government
Answer: The Patient Safety Commissioner (PSC) wrote to the Prime Minister on 16 June, requesting information regarding internal and cross-Government discussions in relation to the Hughes Report, actions that have been taken beyond the Department, the future plans...
Answered 3 Jul 2026
Original Parliament recordHemiplegia: ChildrenDepartment of Health and Social CareTabled 21 May 2026AnsweredUIN 3740More
Question: To ask the Secretary of State for Health and Social Care, if he will make it his policy to promote the drafting of NICE guidelines on early intervention by clinicians to treat infants diagnosed with Hemiplegia; and what recent assessment his department ha
Answer: There are no current plans to commission the National Institute for Health and Care Excellence (NICE) to develop guidelines specifically on the treatment of hemiplegia in infants. Topics for new or updated NICE guidance are identified through its establis...
Answered 2 Jun 2026
Original Parliament recordNaloxoneDepartment of Health and Social CareTabled 20 Feb 2026AnsweredUIN 113436More
Question: To ask the Secretary of State for Health and Social Care, if he will take steps to increase awareness of naloxone as an effective emergency treatment among (a) people at risk of opioid overdose and (b) people who may witness an opioid overdose.
Answer: Naloxone forms a key part of the Government’s plan to reduce drug‑related deaths, and we are committed to raising awareness of, and expanding access to, naloxone across the country.In 2024, the Government amended the Human Medicines Regulations 2012. This...
Answered 16 Mar 2026
Original Parliament recordPatients: TravelDepartment of Health and Social CareTabled 9 Feb 2026AnsweredUIN 111607More
Question: To ask the Secretary of State for Health and Social Care, what plans he has for financial support for patients required to travel very long distances to access (a) stem cell transplants, (b) CAR-T immunotherapy and (c) other specialist treatments; what re
Answer: No such assessment has been made, and there are no current plans to amend the Healthcare Travel Costs Scheme (HTCS).It is already the case that where required and appropriate, advance payments may be made to patients on low incomes to allow them to attend...
Answered 13 Feb 2026
Original Parliament recordProstate Cancer: ScreeningDepartment of Health and Social CareTabled 9 Feb 2026AnsweredUIN 111606More
Question: To ask the Secretary of State for Health and Social Care, whether the recent review by the UK National Screening Committee of evidence on prostate cancer screening considered the potential value for money of adopting (a) shorter and (b) simplified MRI pro
Answer: The evidence considered by the UK National Screening Committee (UK NSC) is available in the consultation on their prostate cancer recommendation page at the following link:https://view-health-screening-recommendations.service.gov.uk/prostate-cancer/The pa...
Answered 2 Mar 2026
Original Parliament recordProstate Cancer: ScreeningDepartment of Health and Social CareTabled 9 Feb 2026AnsweredUIN 111605More
Question: To ask the Secretary of State for Health and Social Care, what the average national unit cost is to the NHS for a local anaesthetic transperineal prostate biopsy, used in prostate cancer detection; and how that cost is calculated.
Answer: The information requested is not held centrally. The cost of a local anaesthetic transperineal prostate biopsy can vary between National Health Service providers, depending on local commissioning arrangements, workforce models, and operational costs.
Answered 2 Mar 2026
Original Parliament recordParkinson's Disease: ResearchDepartment of Health and Social CareTabled 12 Jan 2026AnsweredUIN 104607More
Question: To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Parliamentary Under-Secretary of State for Health and Social Care in the Westminster Hall debate on Parkinson's disease on 17 November 2025, col. 230W
Answer: The Department invests over £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR). In the 2024/25 financial year, the NIHR committed £6 million to Parkinson’s disease research thro...
Answered 16 Jan 2026
Original Parliament recordMefloquine: VeteransDepartment of Health and Social CareTabled 12 Jan 2026AnsweredUIN 104605More
Question: To ask the Secretary of State for Health and Social Care, what steps he has taken with the Secretary of State for Defence to ensure that NHS practitioners are informed of the vulnerability to suicidal ideation of veterans impacted by Lariam; and what step
Answer: The Medicines and Healthcare products Regulatory Agency (MHRA) has updated its safety advice on mefloquine to reflect the risk of neuropsychiatric side effects, advising that it should not be used for chemoprophylaxis in individuals with a history of psyc...
Answered 21 Jan 2026
Original Parliament recordDepartment of Health and Social Care: Written QuestionsDepartment of Health and Social CareTabled 13 Nov 2025AnsweredUIN 90651More
Question: To ask the Secretary of State for Health and Social Care, when he will answer Question 85056 on Prostate Cancer: Medical Treatments, tabled on 26 October for named day response by 30 October.
Answer: I refer the hon. Member to the answer I gave on 21 November 2025 to Question 85056.
Answered 21 Nov 2025
Original Parliament recordPalliative Care: ChildrenDepartment of Health and Social CareTabled 12 Nov 2025AnsweredUIN 90094More
Question: To ask the Secretary of State for Health and Social Care, if he will develop a plan to organise children’s palliative care services on a similar basis to the Operational Delivery Networks in use for neonatal care.
Answer: The Department and NHS England are currently working at pace to develop plans on how best to improve the access, quality, and sustainability of all-age palliative care and end of life care in line with the 10-Year Health Plan.We will closely monitor the s...
Answered 17 Nov 2025
Original Parliament recordEar, Nose and Throat Conditions: SurgeryDepartment of Health and Social CareTabled 3 Nov 2025AnsweredUIN 87211More
Question: To ask the Secretary of State for Health and Social Care, what recent representations he has received from ENT UK on the decision by NHS Hampshire and Isle of Wight Integrated Care Board to refuse all future referrals for (a) septoplasty and (b) other sep
Answer: The Department has received correspondence about the NHS Hampshire and Isle of Wight Integrated Care Board’s (ICB) recent decision from ENT UK along with the British Rhinological Society, the Association of Otolaryngologists in Training, the British Socie...
Answered 11 Nov 2025
Original Parliament recordCoronavirus: VaccinationDepartment of Health and Social CareTabled 3 Nov 2025AnsweredUIN 87210More
Question: To ask the Secretary of State for Health and Social Care, on what evidential basis the minimum age for free covid-19 inoculations to be offered by the NHS, other than for people with particular vulnerabilities, was set at 75; and what information his Depa
Answer: The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI).The primary aim of the national COVID-19 vaccination programme remains the...
Answered 11 Nov 2025
Original Parliament recordOmaveloxoloneDepartment of Health and Social CareTabled 3 Nov 2025AnsweredUIN 87209More
Question: To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the reasons for the difference in availability of Omaveloxolone (Skyclarys) as a treatment for Friedrich's ataxia in (a) Scotland and (b) England a
Answer: The Department has made no assessment of the reasons for the difference in the availability of omaveloxolone (Skyclarys) as a treatment for Friedrich's ataxia in Scotland, England, and Wales.Decisions on the availability of medicines are taken by the resp...
Answered 11 Nov 2025
Original Parliament recordPsilocybin: Clinical TrialsDepartment of Health and Social CareTabled 28 Oct 2025AnsweredUIN 85688More
Question: To ask the Secretary of State for Health and Social Care, whether he has received evidence on the potential clinical use of psilocybin under controlled conditions to treat serious psychiatric illness; whether his Department has made an assessment of the p
Answer: The Medicines and Healthcare Products Regulatory Agency (MHRA) is an executive agency of the Department and regulates medicine, medical devices, and blood components for transfusion in the United Kingdom, with responsibility for ensuring medicines meet ap...
Answered 3 Nov 2025
Original Parliament recordProstate Cancer: Medical TreatmentsDepartment of Health and Social CareTabled 27 Oct 2025AnsweredUIN 85056More
Question: To ask the Secretary of State for Health and Social Care, with reference to the National Cancer Audit Collaborating Centre's report entitled National Prostate Cancer Audit State of the Nation Report 2025, published in October 2025, what assessment his Dep
Answer: The Department is committed to getting the National Health Service diagnosing prostate cancer earlier, and treating it faster, so that more patients survive.The National Cancer audits are an essential tool in understanding variation in access to treatment...
Answered 21 Nov 2025
Original Parliament recordProstate Cancer: ScreeningDepartment of Health and Social CareTabled 8 Sept 2025AnsweredUIN 75558More
Question: To ask the Secretary of State for Health and Social Care, how many and what proportion of PSA tests have (a) accurately diagnosed, and (b) given false (i) negative and (ii) positive diagnoses for prostate cancer in the most recent year for which figures a
Answer: The National Disease Registration Service (NDRS) in NHS England collects diagnosis and treatment data on cancer patients in England. NDRS does not hold information on the specific results of the prostate specific antigen test in the format requested.
Answered 11 Sept 2025
Original Parliament recordProstate Cancer: ScreeningDepartment of Health and Social CareTabled 8 Sept 2025AnsweredUIN 75557More
Question: To ask the Secretary of State for Health and Social Care, what his policy is on (a) routine PSA testing for males in specific age categories and (b) the reimbursement of GP practices by the NHS for providing PSA tests; and whether he has made an assessmen
Answer: There is no age limit on prostate specific antigen (PSA) tests.Advice for general practitioners (GPs) called the Prostate Cancer Risk Management Programme provides information and guidance for GPs to counsel asymptomatic men about the potential benefits a...
Answered 11 Sept 2025
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →